Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
$83.5 - $98.47 $33,400 - $39,388
-400 Closed
0 $0
Q3 2020

Oct 09, 2020

BUY
$82.14 - $91.0 $32,856 - $36,400
400 New
400 $34,000
Q2 2020

Jul 07, 2020

SELL
$80.93 - $91.1 $4,289 - $4,828
-53 Closed
0 $0
Q1 2020

Apr 20, 2020

SELL
$70.67 - $99.01 $218,652 - $306,336
-3,094 Reduced 98.32%
53 $4,000
Q4 2019

Jan 27, 2020

BUY
$84.35 - $95.37 $27,245 - $30,804
323 Added 11.44%
3,147 $297,000
Q3 2019

Oct 09, 2019

SELL
$85.54 - $94.26 $2,138 - $2,356
-25 Reduced 0.88%
2,824 $245,000
Q2 2019

Aug 01, 2019

SELL
$75.4 - $92.8 $1,281 - $1,577
-17 Reduced 0.59%
2,849 $260,000
Q1 2019

Apr 25, 2019

SELL
$75.32 - $86.15 $124,503 - $142,405
-1,653 Reduced 36.58%
2,866 $275,000
Q4 2018

Jan 14, 2019

BUY
$73.66 - $82.02 $37,271 - $41,502
506 Added 12.61%
4,519 $387,000
Q3 2018

Oct 18, 2018

BUY
$66.94 - $77.43 $69,550 - $80,449
1,039 Added 34.94%
4,013 $0
Q1 2018

Apr 25, 2018

SELL
$70.39 - $84.15 $22,595 - $27,012
-321 Reduced 9.74%
2,974 $240,000
Q4 2017

Jan 19, 2018

BUY
$72.33 - $77.64 $238,327 - $255,823
3,295
3,295 $276,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track True Private Wealth Advisors Portfolio

Follow True Private Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on True Private Wealth Advisors with notifications on news.